Гормонотерапия в акушерстве и гинекологии. Иллюзии и реальность

Diamond M., LLacuna A., Wong C. L. Sex behavior after neonatal progesterone, testosterone, estrogen, or antiandrogens. Horm. Behav., 1973; 4:73–88.

Dickens C. Household words. 1852; 95:385–389.

Dilley A., et al. von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstet. Gynecol., 2001; 97:630–636.

Ding Y. Q., et al. Progesterone stimulates calcitonin gene expression in the uterus during implantation. Endocrinol., 1994; 135:2265–2274.

Dodd J. M., et al. Prenatal administration of progesterone for preventing preterm birth [review]. Cochrane Database Syst. Rev., 2006; 2:CD004947.

Dodd J. M., et al. Progesterone for the prevention of preterm birth. Obstet. Gynecol., 2008; 112:127–134.

Dodd J. M., et al. Progesterone supplementation for preventing preterm birth: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2005;84:526–533.

Doglioni C, et al. Immunocytochemical localization of progesterone receptors in endocrine cells of the human pancreas. Am. J. Pathol., 1990; 137:999–1005.

Doldi N., et al. Polycystic ovary syndrome: anomalies in progesterone production. Hum. Reprod., 1998; 13:290–293.

Domenice S., et al. Mutations in the SRY, DAX1, SF1 and WNT4 genes in Brazilian sex-reversed patients. Braz. J. Med. Biol. Res., 2003; 36 (12):145–150.

Dong Y. L., et al. Regulation of inducible nitric oxide synthase messenger ribonucleic acid expression in pregnant rat uterus. Biol. Reprod., 1998; 59:933–940.

Donnet M. L., et al. Return of ovarian function following spontaneous abortion. Clin. Endocrinol. (Oxf.), 1990; 33:13–20.

Doody K. J., et al. Endometrin for luteal phase support in a randomized, controlled, open-label, prospective IVF clinical trial using a combination of Menopur and Bravelle. Fertil. Steril., 2009; 91:1012–1017.

Doyle E. FRI Briefings, Human safety of hormone implants used to promote growth in cattle. Food Research Institute, University of Wisconsin, Madison, 2000.

Dressing G. E., et al. Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models. Endocrine Related Cancer, 2009; 16:351–361.

Druckmann R., Druckmann M. A. Progesterone and the immunology of pregnancy. J. Steroid. Biochem. Mol. Biol., 2005; 97:389–396.

Drummond-Robinson G., Asdell S. A. The relation between the corpus luteum and the mammary glan. J. Physiol., 1926, August 6; 61 (4):608–614.

Dube J., Ngo-Thi N., Tremblay R. In vivo effects of steroid hormones on the testosterone 5-alpha-reductase in rat skin. Endocrinol., 1975; 97:211–214.

Duggavathi R., Murphy D. B. Ovulation Signals. Science, 2009; 324:890–891.

Dutt R. H., Casida L. E. Alteration of the estrual cycle in sheep by use of progesterone and its effect upon subsequent ovulation and fertility. Endocrin., 1948; 43:208.

Eblen A. C., et al. Alterations in humoral immune responses associated with recurrent pregnancy loss. Fertil. Steril., 2000; 73:305–313.

Echternkamp S. E., Lunstra D. D. Relationship between LH and testicular development in progesterone-implanted prepubertal ram lambs. J. Anim. Sci., 1984; 59:441–453.

Edefonti V., et al. Nutrient dietary patterns and the risk of breast and ovarian cancers. Int. J. Cancer, 2008; 122:609–613.

Edelstein M. C., et al. Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil. Steril., 1990; 54:853–857.

Edgren R. A., Stanczyk F. Z. Nomenclature of the Gonane Progestins. Contraception, 1999; 60 (6):313.

Edlund M., Andersson E., Fried G. Progesterone withdrawal causes endothelin release from cultured human uterine microvascular endothelial cells. Hum. Reprod., 2004; 19 (6):1272–1280.

Edson M. A. et al. The mammalian ovary from genesis to revelation. Endocrine Reviews, 2009; 30 (6):624–712.

Eisenbach M., Giojalas L. C. Sperm guidance in mammals — an unpaved road to the egg. Nature Rev. Mol. Cell. Biol., 2006; 7:276–285.

Eldred S. M. Menstruation Myths. New Moon, 1998; 5.6:40.

Elovainio M., et al. Depressive symptoms as predictors of discontinuation of treatment of menorrhagia by levonorgestrel-releasing intrauterine system. Int. J. Behav. Med., 2007; 14:70–75.

El-Zibdeh M. Y. Dydrogesterone in the reduction of recurrent spontaneous abortion. J. Steroid. Biochem. Mol. Biol., 2005; 97:431–434.

Emera D., Romero R., Wagner G. The evolution of menstruation: A new model for genetic assimilation. Bioessays, 2011; 34: 26–35.

Endocrine Society. Bioidentical hormones: position statement. 2006. http://www.endosociety.org/advocacy/policy

Ericson A., Kallen B. Congenital malformations in infants born after IVF: a population-based study. Hum. Reprod., 2001; 16:504–509.

Ertman N., Andreano J. M, Cahill L. Progesterone at encoding predicts subsequent emotional memory. Learn Mem., 2011; 18:759–763.

Esplin M. S., et al. Estimating recurrence of spontaneous preterm delivery. Obstet. Gynecol., 2008 112 (3):516–523.